Speakers
We are happy to have the following speakers confirmed for the event.
Bruce Arroll
Professor of General Practice at the Auckland Medical School.
Bruce Arroll is a graduate from the University of Auckland and spent a year at McMaster University in Hamilton, Ontario and had his first exposure to Clinical Epidemiology there. He spent the next 6 years working in Canada completing a Masters degree in Clinical Epidemiology at the University of British Columbia. He returned to New Zealand to do a PhD in Epidemiology. After three years he joined the Department of General Practice at the University of Auckland and has been there ever since. Having attended the meeting that established the Australasian Cochrane Centre he has been involved in four Cochrane reviews. He is currently the chapter editor for the common cold for the British Medical Journal Evidence based textbook called Clinical Evidence. He has an ongoing interest in trying to reduce the use of antibiotics in viral respiratory infections with a specific interest in the use of delayed prescriptions. He is also interested in screening for lifestyle and mental health issues in primary care.
Lisa Bero
Co-Director, San Francisco Branch Cochrane Center – Professor, Department of Clinical Pharmacy, School of Pharmacy – Professor, Institute for Health Policy Studies, School of Medicine – Vice Chair – Research, Department of Clinical Pharmacy.
Lisa A. Bero, PhD is a Professor, Department of Clinical Pharmacy and Faculty member, Institute for Health Policy Studies, University of California, San Francisco. She is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She has developed and validated methods for assessing bias in research and scientific publication and measures influences on the quality of research, including university-industry relations. Dr. Bero teaches a core course on critical appraisal of the medical literature for pharmacy students and lectures across campus on topics including meta-analysis, research translation and tobacco control policy. She has designed and implemented a curriculum that examines the influences of pharmaceutical industry marketing.
Dr. Bero's international activities include advisor to the World Health Organization Drug Action Programme as a member of the WHO Essential Medicines Committee and member of the Pan American Health Organization Advisory Committee on Health Research. She is Co-Director of the San Francisco Branch of the United States Cochrane Center. She is a senior editor for Tobacco Control and editor for the Cochrane Effective Practice and Organization of Care Group — an international group of researchers conducting meta-analyses of the literature on interventions aimed at getting research into practice. She is an elected member of the Cochrane Collaboration Steering Group and serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.
Chris Del Mar
Pro-Vice Chancellor (Research) and former Dean of the Faculty of Health Sciences and Medicine at Bond University, Gold Coast, Queensland
Professor Del Mar has undertaken research into health services and also clinical areas with over 200 research papers, reviews, book chapter and books. He is a Coordinating Editor of the international Cochrane Collaboration, and am Associate Editor of Evidence Based Medicine, and Clinical Evidence. He was Chair of the Royal Australian College of General Practitioners (RACGP) National Research Committee, was Editor of the research section of the Australian Family Physician until 2006, a member of the Therapeutic Guidelines expert committee on Respiratory Disease from 2009, and an editorial Advisory board of the Australian Medicine Handbook from 2007. He was President of the Australian Association for Academic General Practice, and chair the editorial committee of the Australian Government's health web portal, HealthInsite. In 2007 Professor Del Mar was appointed Visiting Professor at Oxford University's Department of Public Health and Primary Care for 3 years.
Cindy Farquhar
Cindy Farquhar, MB ChB MD MRCOG FRANZCOG CREI MPH is the Postgraduate Professor of Obstetrics and Gynaecology at the University of Auckland. Her research interests include clinical trials within subfertility and menstrual disorders, systematic reviews and clinical practice guidelines. In 2000, Cindy was a Harkness Fellow for the Commonwealth Fund and spent one year at the Agency for Healthcare Research and Quality in Washington, DC. Her clinical interests are polycystic ovarian syndrome, pelvic pain, endometriosis and the management of abnormal uterine bleeding. Cindy has lead guideline development groups on heavy menstrual bleeding, uterine fibroids and the management of women with breech presentation and vaginal birth after caesarean section, as well as assisting with training in guideline development workshops in NZ. Until 2009 Cindy was the chair of the NZGG. From December 2009 Cindy is the Independent Chair of the Steering Group of the Greater Auckland Integrated Health Netowrk (GAIHN) which is a consortium of 11 Primary Health Care Organisations and the 3 Auckland DHBs.
John Fraser
Manager NZGG.
John's role is to identify providers interested in better applying evidence, understand their agenda for change, and then offer them a range of supports – first to deliver their planned change and then to properly cement it into 'business as usual'.
John studied economics and management as an undergraduate, and epidemiology and medical sociology at post graduate level. He has wide health management experience from roles in both the NHS and New Zealand health sector, as well as health research experience.
John came to NZGG from Victoria University where he was a Senior Research Fellow at the Health Services Research Centre. In that role he managed a national evaluation of New Zealand's clinical points score and booking systems for elective surgery, as well as projects evaluating primary care reform, access to services for rural populations, and options for syndromic surveillance systems implementation in New Zealand. Prior to this, John worked in West Auckland in a community engagement and change management role during the transition to the District Heath Board structure.
Peter Gotzsche
Director of The Nordic Cochrane Centre and Lecturer in medical science theory and ethics, Rigshospitalet, Denmark
Born 1949. Master of science in biology and chemistry 1974, physician 1984, specialist in internal medicine 1995. Worked with clinical trials and regulatory affairs in the drug industry 1975 to 1983, and at hospitals in Copenhagen 1984 to 1995. Peter Gøtzsche cofounded The Cochrane Collaboration in 1993 and established The Nordic Cochrane Centre in 1993. Director of The Nordic Cochrane Centre since 1993, chief physician at Rigshospitalet since 1997, and lecturer in theory of medicine, University of Copenhagen, since 1990. At the course in theory of medicine, we use the textbook "Rational Diagnosis and Treatment. Evidence-Based Clinical Decision-Making". Peter has published the 3rd edition of this book with professor Henrik R. Wulff, and the 4th edition as sole author, in 2007. The book has also appeared in Danish, Croatian, Italian, Dutch, Icelandic, Polish, Swedish and Spanish.
Sally Green
Professor in the Faculty of Medicine, Nursing and Health Sciences at Monash University
Sally Green joined the Australasian Cochrane Centre in 1999 and became Director in 2002. She is a Professor in the Faculty of Medicine, Nursing and Health Sciences at Monash University. She holds a PhD in Epidemiology and Preventive Medicine from Monash University, in addition to her clinical qualifications in physiotherapy.
Sally is an active Cochrane review author with the Cochrane Musculoskeletal Group. Her research interests include systematic review methodology (updating reviews and the management of continuous data), clinical trials of interventions for musculoskeletal disorders, implementation strategies, and the appropriate assessment of health outcomes. She is a member of the Cochrane Collaboration Steering Group, co-convenes the Collaboration's Quality Advisory Group and Handbook Advisory Group, and is co-editor of the Cochrane Handbook for Systematic Reviews of Interventions.
Jeremy Grimshaw
Director, Clinical Epidemiology Program – Ottawa Health Research Institute – Cochrane Collaboration Strategic Review Team
Dr Jeremy Grimshaw has recently taken up the positions of Director of the Clinical Epidemiology Programme of the Ottawa Health Research Institute and Director of the Center for Best Practice, Institute of Population Health, University of Ottawa. He holds a Tier 1 Canadian Research Chair in Health Knowledge Transfer and Uptake and is a Full Professor in the Department of Medicine, University of Ottawa. Prior to this he held a Personal Chair in Health Services Research at the University of Aberdeen, UK and was the Programme Director of the Effective Professional Programme within the Health Services Research, probably the largest implementation research programme within the UK.
He will establish a comparable programme in Ottawa. His research interests can be grouped into three themes. Firstly systematic reviews professional, organisational, financial and regulatory interventions to improve professional and health care system performance. He is the Co-ordinating Editor of the Cochrane Effective Practice and Organisation of Care group (which currently has 27 reviews and 20 protocols), has undertaken reviews of guideline dissemination and implementation strategies and overviews of published systematic reviews. He has considerable experience of undertaking systematic reviews of complex interventions and has developed methods for searching for and assessing the quality of cluster randomised controlled trials and quasi experimental designs. He organised a workshop on Complexity and Systematic Reviews for the US Congress Office of Technology Assessment in 1995 and has run similar workshops at Cochrane Colloquia
Russell Gruen
Associate Professor of Surgery, Monash University and The Alfred Hospital, Australia
Russell Gruen is Professor of Surgery and Public Health at Monash University, Director of the National Trauma Research Institute, and is a surgeon and head of Trauma Quality Assurance at The Alfred Hospital.
Russell graduated in medicine from the University of Melbourne, trained in general surgery at St Vincent's Hospital, Melbourne, and then in trauma surgery and surgical critical care at Harborview Medical Centre in Seattle, USA. From 2006 to 2009 he was Associate Professor of Surgery at the University of Melbourne and Royal Melbourne Hospital.
Russell aims to support the integration of high quality research, clinical practice and policy decision-making, and has had a variety of research and policy experiences. He received a PhD for his study of the delivery of surgical services to remote and disadvantaged Aboriginal communities in northern Australia. In 2002-2003 he was a Harkness Fellow in Health Care Policy and a Fellow in Medical Ethics at Harvard University in Boston, USA, studying medical professionalism and the public roles of doctors.
The focus of Russell's recent research has been clinical quality improvement, optimising systems of surgical and trauma care, and improving the use of evidence in clinical and health policy decision-making. He is an editor of the Effective Practice and Organisation of Care Group in the Cochrane Collaboration. He also established the Global Evidence Mapping (GEM) Initiative to bring together a network of people and organisations to develop innovative methods of characterising, contextualising and increasing the accessibility of research in broad clinical areas, and he leads a program of translational research in traumatic brain injury.
Russell has received research funding totalling more than $6 million, holds an NH&MRC Career Development Award, and has authored over 55 publications in peer-reviewed journals, including the Lancet, JAMA and the New England Journal of Medicine. He has also been awarded a RACS G. J. Royal Medal, a General Surgeons Australia Medal, and a Travelling Fellowship of the James IV Association of Surgeons.
Russell and his wife, Theresa, have two sons, Spencer and Kody, with whom he enjoys playing music and pursuing outdoor activities, especially football and biking.
Peter Herbison
Associate Professor , HOD, Preventive & Social Medicine, Health Sciences, Dunedin School of Medicine
Associate Professor Peter Herbison is a statistician who has been helping health researchers for over 30 years. His interests tend to be based around current problems, but include consulting technique, analysis of longitudinal data,systematic reviews and meta-analysis, analysis of crossover studies and computing.
He has been involved with the Cochrane Collaboration since 1995 and is the statistical editor on two Cochrane Review Groups, the ncontinence Group and the Bone, Joint and Muscle Trauma Group
Julian Higgins
Senior Statistician at the MRC Biostatistics Unit, Cambridge, UK
Julian Higgins is a Senior Statistician at the MRC Biostatistics Unit in Cambridge, UK, where he leads a research programme in methods for evidence synthesis. He is co-editor of the 'Cochrane Handbook for Systematic Reviews of Interventions' (Wiley 2008) and 'Human Genome Epidemiology (Second Edition): Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease' (OUP, 2009), and co-author of 'Introduction to Meta-analysis' (Wiley 2009) and numerous methodological and applied papers on systematic reviews and meta-analyses. Julian is currently the Methods Groups representative
on the Cochrane Collaboration Steering Group.
Rod Jackson
Professor of Epidemiology in the Section of Epidemiology & Biostatistics at the School of Population Health, University of Auckland
Rod Jackson is a professor of Epidemiology in the Section of Epidemiology & Biostatistics at the School of Population Health, University of Auckland, New Zealand. He is medically trained, has a PhD in Epidemiology and is a member of the New Zealand College of Public Health Medicine. He teaches epidemiology and its applications in public health and healthcare practice at undergraduate and postgraduate levels both in New Zealand and internationally.
His main research interest for over 25 years has been the epidemiology of cardiovascular diseases. He is one of the architects of New Zealand risk-based clinical guidelines for managing CVD risk and leads a team that developed the PREDICT programme which uses a web-based clinical decision support system to simultaneously get evidence, about CVD risk and risk management, into and out of clinical practice. PREDICT has been used over 200,000 times by over 1,000 clinicians in routine practice.
Rod also directs EPIQ, a collaboration of academics and health professions who work in the overlapping fields of Effective Practice,
Informatics and Quality Improvement (www.epiq.co.nz). He has published over 200 peer-reviewed papers.
Mark Jeffery
Medical Oncologist, Christchurch Hospital
Mark Jeffery has over 20 years of clinical experience as a cancer specialist. He has maintained a career long interest in issues relating to the evidence underlying clinical practise and is an active participant in cancer clinical trials. In 1996 he received a National Health Committee Fellowship in Leadership in Guideline Development and Implementation and is a board member of the New Zealand Guidelines Group. Mark has been involved with the Cochrane Collaboration since 1999. He is a Cochrane review author, an editor with the Cochrane Colorectal Cancer Group and co-director of the NZ Branch of the Australasian Cochrane Centre.
Alessandro Liberati
Professor Alessandro Liberati, AL, University of Modena and Reggio Emilia and Italian Cocharne Centre, Mario Negri Institute, Milan, Italy
Alessandro Liberati is currently Associate Professor of Medical Statistics at the Medical School University of Modena and Reggio Emilia and Director of the Italian Cochane Centre.
After his medical degree obtained at the University of Milano Medical School in 1978 Dr. Liberati started his research career as Research Fellow at the Laboratory of Clinical Pharmacology of the Mario Negri Institute in Milano. In 1981 he got his Post-Doctoral Degree in Hygiene and Public Health subsequently spent a training period as Research Fellow at the Departments of Epidemiology and Health Policy and Management of the Harvard School of Public Health in Boston (USA). During his stay (1983-84) in the USA Dr. Liberati was trained in epidemiology and biostatistic with special reference to the methodology of Health Services Research. Upon his return in Italy in 1985 Dr. Liberati concentrated on research in the areas of quality of care assessment in oncology (with special reference to the study of determinants of physicians behavior) and evaluation of the quality and reliability of the scientific literature.
In 1986 he founded a cooperative research group (G.I.V.I.O. Interdisciplinary Group for Cancer Care Evaluation) including 63 general and community hospitals to carry out multicentre controlled trials on the effectiveness of therapeutic interventions as well as studies on quality of care in oncology. In this capacity he also contributed to the diffusion and adoption of standardized tools for quality of life assessment in clinical trials within Italy and coordinated in 1991 a national study aimed at assessing the impact of national guidelines for the treatment of breast, ovarian and colo-rectal cancer.
Since April 2004 he is Consultant for the Research and Innovation Program of the Agenzia Sanitaria Regionale of Regione Emilia Romagna, Bologna. He is member (since 2005) of the National Committee for Health Research of the Ministry of Health and of the Research & Development Committee of the Italian Drug Agency (AIFA). Since 2001 he is Scientific Director of the Italian version of Clinical Evidence. Dr. Liberati's research activities are documented in over 300 scientific publications (of which 197 in English language peer-reviewed journals). He was member of the Editorial Board of British Medical Journal between 1996 and 2000 and served in the Editorial Boards of Annals of Internal Medicine and. He is currently member of the Editorial Board of the Journal of Clinical Epidemiology and the Journal of Health Services Research and Policy. He is regular Referee for several international medical journals.
Dr. Liberati's most significant contributions are in the following areas: a) Assessment of the quality of the medical literature; b) Methodology of systematic reviews and metanalysis with particular reference to oncology, cardiovascular diseases, ophthalmology and intensive care medicine; c) Analysis of determinants of compliance to practice guidelines in oncology; d) Methodology for the production and assessment of practice guidelines; e) Assessment of the effectiveness of long-term care interventions.
Holger Schunemann
Chair, Department of Clinical Epidemiology & Biostatistics Michael Gent Chair in Healthcare Research Professor of Clinical Epidemiology, Biostatistics and Medicine
As internist and clinical epidemiologist, Holger J. Schünemann holds the position of chair of the department of Clinical Epidemiology and Biostatistics at McMaster University, Hamilton, Canada, the birthplace of problem based learning and evidence based medicine. He co-convenes the Applicability and Recommendations Method Group of the Cochrane Collaboration and is co-chair of the GRADE working group. His current academic interest focuses on improving methods and collaboration in evidence syntheses and guideline development. He has developed guidelines with a variety of organizations including the WHO, the World Allergy Organization, the American Thoracic Society and other professional societies and supported regional and local agencies in guideline development projects.
He authored over 300 peer reviewed publications, books and book chapters, many of them focusing on guideline methodology. His other research focuses on systematic review methods, study design, information presentation, quality of life research methodology and respiratory medicine. As inaugural documents editor of the American Thoracic Society (ATS), an internationally leading professional society for respiratory, critical care and sleep medicine, he is responsible for guideline and other official document development for the ATS. He is editor-in-chief of the Health and Quality of Life Outcomes, associate editor of the American College of Physician's Journal Club and co-chair (Methodology) of the American College of Chest Physicians (ACCP) Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.
He graduated from the Medical School of Hannover, Germany, in 1993, and trained in epidemiology (Ph.D. in 2000), preventive medicine/public health and internal medicine (US Board Certification) at the Medical School of Hannover, Germany, and at the State University of New York (SUNY) at Buffalo, USA.
Prathap Tharyan
Professor of Psychiatry and Director, Christian Medical College, Vellore,Tamil Nadu, India
Prathap Tharyan, Professor of Psychiatry, trained for the MBBS degree and for the postgraduate Degree MD (Psychiatry) at the Christian Medical College, Vellore, Tamil Nadu, and for the Membership of the Royal College of Psychiatrists (MRCPsych) at Oxford, UK. He was former Head of the Department of Psychiatry and former additional Vice-Principal (Research) at CMC. He currently serves as an Associate Director of CMC, Vellore.
Dr. Tharyan is the Director of the South Asian Cochrane Network & Centre that is hosted by the Prof. BV Moses & Indian Council for Medical Research Centre for Advanced Research and Training in Evidence-Informed Healthcare at CMC Vellore. The Centre supports the activities of network sites in India, Pakistan, Bangladesh, and Sri Lanka, and hopes to expand its support to review authors in Bhutan, Bangladesh and Nepal. He is an Editor with the Cochrane Schizophrenia Group and a systematic review author with several other Cochrane review groups. He is a program partner and member of the executive of the DFID-funded Effective Healthcare Research Partnership Consortium that seeks to provide evidence for the effects of interventions relevant to the MDGs and increase capacity for research synthesis in low and middle income countries. He is an Associate Editor with the open access journal Trials and of The Journal of Evidence Based Medicine. He serves on the steering group of the Clinical Trials Registry-India and is a member of the WHO Expert Panel on Guidelines Development, Ethics and Clinical Trials.
David Tovey
Editor in Chief, The Cochrane Library
Dr David Tovey qualified in Medicine from Bristol University in the UK. He was a GP in an urban practice in South London for 14 years, and combined this with work in continuing medical education. In 2003 he left general practice and moved to the BMJ, where he became Deputy Editor, then Editor of Clinical Evidence. For the last two years he has been Editorial Director of the BMJ Evidence Centre, with responsibility for Clinical Evidence, its sister product BestTreatments aimed at the public, and the development of both the new BMJ Point of Care online product, and order entry sets in association with the Cerner Corporation. He was appointed as Editor in Chief of the Cochrane Library in late 2008, and started work for the Collaboration in January 2009.
Tari Turner
Tari Turner is a Senior Research Fellow with the National Trauma Research Institute at Monash University in Melbourne Australia. Tari completed a PhD in Health Services Research focusing on the value and feasibility of developing evidence-based clinical practice guidelines in hospitals in South East Asia and Australia. She is passionate about supporting the synthesis and use of research evidence to improve healthcare decision-making, particularly in situations of great need.
Jim Vause
Chairperson of the NZGG. General Practitioner, Blenheim, New Zealand.
A general practitioner since 1979 and currently resident in Blenheim, Jim has been involved in guideline development since 1998 particularly in the realms of cancer diagnosis and screening. He has been a long standing member of the National Screening Advisory Committee and has also had a number of roles in quality in primary care, both for the Royal New Zealand College of General Practitioners and also for the national Quality Improvement Committee. His interest in evidence based medicine has also included being principal webeditor for the World Organisation of Family Physicians, WONCA.
Sue Wells
Senior lecturer of Clinical Epidemiology within the Section of Epidemiology and Biostatistics, School of Population Health, University of Auckland
Sue Wells is a senior lecturer of Clinical Epidemiology within the Section of Epidemiology and Biostatistics, School of Population Health, University of Auckland. She is a Public Health Physician with a background of 10 years general practice. She has worked for the National Heart Foundation (supporting cardiovascular risk assessment in primary care) and the New Zealand Guidelines Group (co-driver Cardiac Rehabilitation guidelines). Since 2002, she has been the Clinical project leader of a primary care web-based electronic decision support programme of cardiovascular(CVD)risk assessment and management, PREDICT-CVD. This is currently being updated to include CVD risk management and the management of Type 2 Diabetes.
Rebecca Armstrong
Senior Research Fellow in Knowledge Translation and Exchange and the Editoral and Methods Advisor for the Cochrane Public Health Group
Rebecca provides methods advice to editors and review authors, maintains national and international partnerships for systematic review development and utilization, develops training packages and coordinate training activities and coordinates Cochrane PHRG research activities. Rebecca is also part of in international research team exploring the effectiveness of knowledge translation and exchange strategies. The intention of this work is to identify activities most likely to support evidence-informed public health decision-making. This work forms the basis of her PhD study.
Silke Kuehl
Clinical Advisor
Silke has been part of the Self-harm and Suicide Prevention Collaborative Whakawhanaungatanga since September 2005. Leaving Germany in 1986, Silke worded and studied in the United Kingdom, Spain and the United States of America before arriving in New Zealand in 2000. Silke is an experienced nurse, both in emergency and mental health, and has worked with undergraduate students at Massey University in the past. She finished her MA (Clinical) in 2008 with a thesis on 'Emergency Department re-presentations following intentional self-harm'. Silke currently divides her time between NZGG, emergency nursing at Capital Coast Health and research in suicide prevention at the University of Otago.
Christine Priestly
Project Leader/Quality Improvement Advisor NZGG.
Christine has worked in many varied and successful roles in healthcare. Originally working in medical laboratory, and after completing postgraduate work on total quality management, she moved to Training and Development work in the finance industry.
From there she took up a Human Resource Consultant position and worked on quality improvement in the education and local body sectors. However the pull of the health sector was still strong and she returned to work in mental health services at Waikato hospital and was responsible for developing the processes and tools for serious incident analysis, other risk management and quality improvement projects and participated in the move of patients to the new inpatient Henry Bennett Centre. Christine also recruited the first consumer advisors to Waikato mental health services and worked closely with family advisors. From there Christine took up a similar role in the general acute part of the hospital where she influential in setting up processes for the Serious Incident Panel.
During a period in the NHS in England Christine set up the clinical effectiveness systems in a large Primary Care Trust, this included implementation of systems to monitor the Quality and Outcome Framework for GPs, and an integrated quality improvement project across secondary and primary care. As Clinical Governance Advisor for the Birmingham and Black Country Strategic Health authority she provided advice to governance managers. Her last NHS role before returning to NZ was as Director of Clinical Governance at the Royal Orthopaedic Hospital Birmingham.
More recently Christine has worked with Healthshare as an auditor and also worked on several projects with the Development and Support Unit of the Waikato DHB.
Teuila Percival
BHB, MBChB (Auckland), FRACP (Paediatrics)
Dr Teuila Percival is a Consultant Paediatrician at Kidz First Children's Hospital, South Auckland & Director of Pacific Health at the School of Population Health, University of Auckland.
Teuila is Samoan with a wealth of clinical and governance experience, including previous chair and current board member of South Seas Healthcare. Current research interests child obesity intervention, Rheumatic fever, clinical indicators for children's health in the Pacific Islands
Liz Whamond
Elizabeth (Liz) Whamond has a long and distinguished history in the Canadian cancer community. In 2001, Ms. Whamond was one of the founding members of the Canadian Cancer Action Network and currently serves as Vice Chair as well as the CCAN representative on the Cancer Journey Action Group of the Canadian Partnership Against Cancer. Until September of 2009, Ms. Whamond also held the role of Chair, CCAN Patient Voice Committee.
In addition to a variety of key leadership roles with various organizations, Ms. Whamond was a co-founder of the New Brunswick Breast Cancer Network and served as its first president from 1995 to 1997. As the first president of the Canadian Breast Cancer Network, Ms. Whamond has been actively involved in cancer advocacy activities at the national level and – at present – is a member of the board of directors of the Canadian Partnership Against Cancer.
Liz first became involved with the Cochrane Collaboration in 1999. She currently serves as the Chair of the Cochrane Consumer Network (CCNet) and sits on the Cochrane Collaboration Steering Group (CCSG).